BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24491909)

  • 1. Interferon gamma peptidomimetic targeted to hepatic stellate cells ameliorates acute and chronic liver fibrosis in vivo.
    Bansal R; Prakash J; De Ruiter M; Poelstra K
    J Control Release; 2014 Apr; 179():18-24. PubMed ID: 24491909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis.
    Bansal R; Prakash J; de Ruijter M; Beljaars L; Poelstra K
    Mol Pharm; 2011 Oct; 8(5):1899-909. PubMed ID: 21800888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted recombinant fusion proteins of IFNγ and mimetic IFNγ with PDGFβR bicyclic peptide inhibits liver fibrogenesis in vivo.
    Bansal R; Prakash J; De Ruiter M; Poelstra K
    PLoS One; 2014; 9(2):e89878. PubMed ID: 24587093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice.
    Poosti F; Bansal R; Yazdani S; Prakash J; Beljaars L; van den Born J; de Borst MH; van Goor H; Hillebrands JL; Poelstra K
    Oncotarget; 2016 Aug; 7(34):54240-54252. PubMed ID: 27509062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats.
    Li F; Li QH; Wang JY; Zhan CY; Xie C; Lu WY
    J Control Release; 2012 Apr; 159(2):261-70. PubMed ID: 22226772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel engineered targeted interferon-gamma blocks hepatic fibrogenesis in mice.
    Bansal R; Prakash J; Post E; Beljaars L; Schuppan D; Poelstra K
    Hepatology; 2011 Aug; 54(2):586-96. PubMed ID: 21538439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
    Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
    J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion.
    Wu Y; Liu X; Zhou Q; Huang C; Meng X; Xu F; Li J
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):163-76. PubMed ID: 26435214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
    Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
    Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ameliorative effect of grape seed proanthocyanidin extract on thioacetamide-induced mouse hepatic fibrosis.
    Li J; Li J; Li S; He B; Mi Y; Cao H; Zhang C; Li L
    Toxicol Lett; 2012 Sep; 213(3):353-60. PubMed ID: 22863721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New role and molecular mechanism of Gadd45a in hepatic fibrosis.
    Hong L; Sun QF; Xu TY; Wu YH; Zhang H; Fu RQ; Cai FJ; Zhou QQ; Zhou K; Du QW; Zhang D; Xu S; Ding JG
    World J Gastroenterol; 2016 Mar; 22(9):2779-88. PubMed ID: 26973416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats.
    Li J; Liu P; Zhang R; Cao L; Qian H; Liao J; Xu W; Wu M; Yin Z
    J Ethnopharmacol; 2011 Sep; 137(1):714-23. PubMed ID: 21726622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Chimeric Protein BiPPB-mIFNγ-tTβRII for Improving the Anti-Fibrotic Activity in Vivo by Targeting Fibrotic Liver and Dual Inhibiting the TGF-β1/Smad Signaling Pathway.
    Dong Y; Wang X; Xu L; Li X; Dai H; Mao X; Chu Y; Yuan X; Liu H
    Protein J; 2023 Dec; 42(6):753-765. PubMed ID: 37690089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines.
    Lu DH; Guo XY; Qin SY; Luo W; Huang XL; Chen M; Wang JX; Ma SJ; Yang XW; Jiang HX
    World J Gastroenterol; 2015 Feb; 21(5):1531-45. PubMed ID: 25663772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis.
    Baroni GS; D'Ambrosio L; Curto P; Casini A; Mancini R; Jezequel AM; Benedetti A
    Hepatology; 1996 May; 23(5):1189-99. PubMed ID: 8621153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
    Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted truncated TGF-β receptor type II delivery to fibrotic liver by PDGFβ receptor-binding peptide modification for improving the anti-fibrotic activity against hepatic fibrosis in vitro and in vivo.
    Huang Z; Ding M; Dong Y; Ma M; Song X; Liu Y; Gao Z; Guan H; Chu Y; Feng H; Wang X; Liu H
    Int J Biol Macromol; 2021 Oct; 188():941-949. PubMed ID: 34389395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycyrrhizic acid inhibits apoptosis and fibrosis in carbon-tetrachloride-induced rat liver injury.
    Liang B; Guo XL; Jin J; Ma YC; Feng ZQ
    World J Gastroenterol; 2015 May; 21(17):5271-80. PubMed ID: 25954100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herb medicine Inchin-ko-to (TJ-135) regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in rats.
    Imanishi Y; Maeda N; Otogawa K; Seki S; Matsui H; Kawada N; Arakawa T
    J Hepatol; 2004 Aug; 41(2):242-50. PubMed ID: 15288473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis.
    Bennett RG; Simpson RL; Hamel FG
    World J Gastroenterol; 2017 Jun; 23(22):3999-4006. PubMed ID: 28652653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.